Xi'an Faithful BioTech Co., Ltd. is selling Retatrutide Raw Powder. Please feel free to contact us if you have any purchase needs.
Send your Inquiry for more details, Click email：sales4@faithfulbio.com
I. Basic Product Attributes: Core Physicochemical and Labeling Information
Raw Powder Retatrutide is a synthetic polypeptide compound belonging to the triple receptor agonist class of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic peptide (GIP), and glucagon. It possesses a well-defined chemical structure and strict physicochemical parameters, which are fundamental to its precise pharmacological action.
1. Core Chemical Labeling
The core chemical information of this product is unique and serves as a key basis for its quality control and identification: English name: Retatrutide; Chemical Abstracts Service (CAS) number: 2381089-83-2; Internationally recognized chemical name: LY3437943. Its molecular formula is C₂₂₁H₃₄₂N₄₆O₆₈, its molecular weight is 4731.35, and its amino acid sequence is clearly defined as H-Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-{20diacid-gamma-Glu-(AEEA)₂-Lys}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Pro-Ser-NH₂. This specific amino acid sequence determines its unique receptor-binding activity.
2. Physicochemical Properties
Raw Powder Retatrutide is a white or off-white lyophilized powder, odorless and tasteless, with good water solubility, reaching 5 mg/ml in water and 3 mg/ml (0.73 mM) in dimethyl sulfoxide (DMSO). This characteristic provides flexible solvent selection for subsequent formulation development. The product has a pH range of 6.0-9.0, meeting the acid-base stability requirements of pharmaceutical-grade raw materials. Heavy metal content is strictly controlled below 10 ppm, and moisture content is ≤10.0% (Kal Fischer method), ensuring product stability during storage and use.
II. Mechanism of Action: Synergistic Effect of Triple Receptor Agonism
Unlike traditional single- or dual-target metabolic regulation products, the core advantage of Raw Powder Retatrutide lies in its "triple agonist" mechanism of action. By simultaneously activating three major receptors-GLP-1, GIP, and glucagon-it synergistically regulates appetite, metabolism, blood glucose, and energy balance, achieving a more significant therapeutic effect than previous generations of drugs. This breakthrough in mechanism marks a new era in the treatment of metabolic diseases, characterized by multi-target synergistic regulation.
1. Precise Activation and Physiological Effects of Three Major Receptors
Retatrutide exhibits clear selectivity and potency in activating three major receptors, exerting synergistic effects through different signaling pathways:
- GLP-1 Receptor Activation: GLP-1 is an intestinal incretin. Retatrutide mimics its action, slowing gastric emptying and prolonging the time food remains in the stomach, thereby significantly enhancing satiety and reducing food intake. Simultaneously, it precisely stimulates insulin secretion and reduces glucagon secretion when blood glucose levels rise, achieving glucose-dependent regulation of blood glucose and avoiding the risk of hypoglycemia. Clinical data show that the half-maximal effective concentration (EC₅₀) of Retatrutide for the human GLP-1 receptor is 0.775 nm, demonstrating significant activation efficacy.
- GIP Receptor Activation: GIP, also an incretin secreted by the intestine, exhibits the strongest activation efficacy at its receptors, with a human GIP receptor EC₅₀ value of only 0.0643 nm. GIP receptor activation regulates lipid metabolism, reduces fat storage in the body, enhances insulin sensitivity, and improves insulin resistance, playing a crucial role in the regulation of metabolic syndrome. Furthermore, GIP can synergistically work with GLP-1 to further enhance appetite suppression.
- Glucagon Receptor Activation: Glucagon is primarily secreted by pancreatic α cells and is responsible for raising blood glucose levels. Moderate activation of its receptors by retatrutide (human GCGR EC₅₀ is 5.79 nm) promotes hepatic gluconeogenesis and glycogenolysis, while simultaneously enhancing energy expenditure. More importantly, it promotes the transformation of white adipose tissue into brown adipose tissue (i.e., "beige-ization of fat"). Brown adipose tissue has highly efficient thermogenesis and energy expenditure characteristics, significantly increasing the body's metabolic rate and fundamentally improving energy balance.
2. Triple Synergistic Metabolic Regulation Effect
The synergistic activation of three major receptors enables Retatrutide to achieve a triple metabolic regulation target of "reduced intake + increased consumption + precise blood sugar control": it suppresses appetite and reduces food intake through the synergistic action of GLP-1 and GIP receptors; it increases energy expenditure and promotes lipolysis through glucagon receptor activation; and it improves glycemic homeostasis through the synergistic effect of GLP-1 and GIP receptors. This multi-dimensional regulatory mechanism gives it a significant therapeutic advantage over single- or dual-target products in weight management and the treatment of metabolic diseases.
Send your Inquiry for more details, Click email：sales4@faithfulbio.com
III. Application Areas: From Pharmaceutical R&D to Multi-Field Expansion
Raw Powder Retatrutide, with its unique pharmacological activity and high purity, has expanded its application areas from core pharmaceutical R&D to multiple fields such as scientific research and daily chemicals, continuously releasing its market potential.
1. Core Application: Metabolic Disease Drug Development
This is the core application area of Raw Powder Retatrutide, primarily focusing on the development of therapeutic products for the following diseases:
- Obesity Treatment Products: Based on its breakthrough weight loss effect, Retatrutide has become a core target ingredient for obesity product development.
- Type 2 Diabetes Treatment Products: Retatrutide's glucose-dependent blood glucose control effect makes it an ideal research ingredient for type 2 diabetes treatment products. Clinical data shows that it can effectively reduce fasting and postprandial blood glucose in diabetic patients, improve insulin resistance, and has a low risk of hypoglycemia, demonstrating significant safety advantages.
- Metabolic Complication Treatment Products: Including non-alcoholic steatohepatitis (NAFLD), metabolic syndrome, obesity-related osteoarthritis, etc. Currently, clinical trials for patients with fatty liver disease are recruiting. The efficacy of retatrutide in improving hepatic fat metabolism and relieving joint pain provides a new direction for the treatment of these complications.
2. Expanding Applications in Daily Chemicals and Health Products
With in-depth research into its physiological activity, the application of Raw Powder Retatrutide has expanded to the daily chemical and health product fields:
- High-end weight loss and weight management products: As a core active ingredient, it is used to develop professional weight management formulations, such as weight loss peptides and metabolic regulation health products, catering to the needs of the high-end health management market.
- Daily chemical beauty products: Utilizing its properties of promoting metabolism and improving skin metabolism, it is incorporated into high-end skincare formulations to develop beauty products with skin-firming and skin-improving effects, exploring the application potential of peptide ingredients in the daily chemical field.
IV. Usage and Storage Guidelines: Ensuring Product Activity and Safety
As a highly active peptide raw material, the standardized operation of Raw Powder Retatrutide during use, storage, and transportation directly affects the activity, purity, and safety of the product. The following are core specifications based on industry standards and supplier requirements:
1. Storage Conditions
Retatrutide is sensitive to temperature, light, and humidity, and must strictly adhere to the following storage requirements:
- Short-term storage: Store at 2-8℃ in a sealed, light-protected environment, avoiding temperature fluctuations. It can be stored for 6 months to 1 year, suitable for short-term research or small-batch production needs.
- Long-term storage: Store at -20℃ or below (some requirements below -25℃) in a sealed, frozen environment, away from light and in a dry place. It can be stored for more than 2 years. For long-term storage, avoid repeated freezing and thawing. It is recommended to aliquot and store one portion at a time to minimize the impact on the overall product activity.
- Storage precautions: Avoid direct sunlight, high temperature and high humidity environments. Avoid storage with strong oxidants, strong acids, strong alkalis, etc., to prevent product degradation or deterioration.
2. Transportation Requirements
Raw Powder Retatrutide must be transported using a professional cold chain transportation method, ensuring that the temperature is controlled at 2-8℃ or below -20℃ throughout the entire process, depending on the transportation time and storage requirements. During transportation, real-time temperature monitoring equipment is required to prevent temperature runaway and subsequent decrease in product activity. Simultaneously, the packaging must be shockproof, light-proof, and airtight to prevent damage and product contamination during transport.
V. Market Prospects and Industry Trends
With the continued rise in the global incidence of metabolic diseases such as obesity and type 2 diabetes, and the increasing demand for healthy weight management, the market size of metabolic regulation products is constantly expanding. Industry forecasts predict that by the 2030s, the global market size for weight loss and diabetes products will reach $100 billion. As a next-generation core product, the market demand for Retatrutide's raw material, Raw Powder Retatrutide, will continue to climb, indicating a promising industry outlook.
1. Market Demand Drivers
- Significant Clinical Efficacy Advantages: Retatrutide's weight loss and blood sugar control effects far exceed those of existing products, and it is expected to become one of the preferred products for the treatment of obesity and type 2 diabetes. The demand for its raw material will grow rapidly with product development progress and post-market clinical application.
- Expanding Application Areas: In addition to its core application in the treatment of metabolic diseases, Retatrutide's applications in the treatment of complications such as fatty liver and osteoarthritis, as well as in the daily chemical and health management sectors, will further expand the market demand for its raw materials.
- Increasing R&D Investment: Major global pharmaceutical companies are increasing their R&D investment in multi-target metabolic regulation products. Retatrutide, as a representative of triple receptor agonists, has become a research hotspot, and the demand for high-purity raw materials in related research and production continues to rise.
2. Industry Development Trends
In the future, the industry will exhibit the following trends: First, continuously improving quality standards. As product development places higher demands on the purity and impurity control of raw materials, suppliers will further optimize production processes to improve product quality. Second, large-scale capacity expansion to meet the large-scale demand for industrial production after product launch. Third, technology-driven innovation, through optimization of synthesis processes and innovation in formulation technology, to further improve product stability and application effects. Fourth, diversified application areas, continuously exploring application potential in more metabolic-related diseases and health fields.
Conclusion
Raw Powder Retatrutide, as a core ingredient in next-generation triple receptor agonists, has become a key ingredient in the treatment of metabolic diseases due to its unique mechanism of action, outstanding clinical efficacy, stringent quality standards, and broad application potential. From its basic physicochemical properties to its complex synergistic mechanisms, from strict usage and storage guidelines to its vast market prospects, every dimension of Raw Powder Retatrutide demonstrates its significant value in pharmaceutical research and development and the healthcare field.
With the continuous deepening of clinical research and the ongoing expansion of its application areas, Raw Powder Retatrutide will play an increasingly important role in the global treatment and health management of metabolic diseases. For practitioners and researchers in related fields, a thorough understanding of its product knowledge and strict adherence to usage guidelines will provide a solid foundation for product development and scientific innovation. In the future, with continuous technological advancements and market development, Raw Powder Retatrutide is expected to drive the treatment of metabolic diseases into a new stage, bringing more effective treatment options to patients worldwide.
As a provider of premium Retatrutide CAS 2381089-83-2, Xi'an Faithful BioTech Co., Ltd. leverages state-of-the-art production technology and rigorous quality assurance to meet international pharmaceutical requirements. Our dedication to superior quality, cost-effective pricing, and tailored technical support has made us the preferred collaborator for healthcare professionals and researchers worldwide. To obtain detailed specifications and application guidance for our Retatrutide Powder, contact our technical team at sales4@faithfulbio.com and explore how our offerings can enhance your product formulations.